TNFSF13B and myeloid sarcoma: Conversely, CSF BAFF levels appeared to be reduced in relapsing MS at clinical onset, particularly in OCGB-positive subjects, suggesting the absorption of this factor by intrathecally recruited B cells from the early phases of the disease [137].